OXFORD, England, September 22, 2025--(BUSINESS WIRE)--OGT, a leading global provider of genomic diagnostic and research solutions, announced today that the U.S. Food and Drug Administration (FDA) has ...

Abbott announced that its Vysis EGR1 FISH Probe Kit has received 501K clearance from the FDA to detect a chromosomal deletion in bone marrow that is usually associated with an unfavorable prognosis ...

ABBOTT PARK, Ill., Aug. 22, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received 510k clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid ...

DES PLAINES, Ill., Oct. 24, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to ...

Bladder cancer is becoming increasingly prevalent, and in 2012 was reported as the 5th most common cancer in Europe (1). While cytology screening is commonplace for diagnosing bladder cancer, a recent ...

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® P16/3c/7c/17c Probe Kit, a cost-effective, ready-to-use fluorescence in situ ...

The CytoCell KMT2A Breakapart FISH Probe Kit PDx is approved as a companion diagnostic for revumenib in KMT2A translocated acute leukemia. Revumenib showed a 21.2% complete remission rate in ...

Oxford Gene Technology has launched its CE-IVD labelled Cytocell Aquarius® P16/3c/7c/17c Probe Kit, a cost-effective, ready-to-use fluorescence in situ hybridisation (FISH) probe kit for non-invasive ...

Oxford Gene Technology (OGT), a molecular genetics company, has launched its CE-IVD labelled Cytocell Aquarius P16/3c/7c/17c Probe Kit, a cost-effective, ready-to-use fluorescence in situ ...

OGT, a leading global provider of genomic diagnostic and research solutions, announced today that the U.S. Food and Drug Administration (FDA) has granted their De Novo Classification Request for the ...